Pure Extracts Technologies Corp. — Investor Relations & Filings
Filings indexed
99
across all filing types
Latest filing
2023-06-29
Regulatory Filings
Country
CA
Canada
Listing
CSE
PULL
Pure Extracts Technologies Corp. is an integrated plant-based extraction company specializing in the processing of cannabis, hemp, and functional mushrooms. The firm focuses on the development and commercialization of functional and medicinal derivatives, including oils and various derivative products. Leveraging extensive extraction and production experience, the company is also active in the rapidly emerging psychedelic sector, specifically through joint ventures for the extraction and formulation of psilocybin. The company operates an EU-GMP compliant facility, ensuring high standards for its specialized plant-based extracts.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Letter from successor auditor.pdf | 2023-06-29 | English | |
| Notice.pdf | 2023-06-29 | English | |
| Letter from former auditor.pdf | 2023-05-29 | English | |
| Notice.pdf | 2023-05-29 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-02-28 | English | |
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-02-28 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
8 filings
| |||||
| 28795376 | Letter from successor auditor.pdf | 2023-06-29 | English | ||
| 28795357 | Notice.pdf | 2023-06-29 | English | ||
| 28522357 | Letter from former auditor.pdf | 2023-05-29 | English | ||
| 28522343 | Notice.pdf | 2023-05-29 | English | ||
| 13648134 | 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-02-28 | English | ||
| 13648133 | 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-02-28 | English | ||
| 13648146 | Interim MD&A - English.pdf | 2023-02-28 | English | ||
| 13648154 | Interim financial statements/report – English.pdf | 2023-02-28 | English | ||
|
2022
7 filings
| |||||
| 25522271 | News release - English.pdf | 2022-08-17 | English | ||
| 25173705 | News release - English.pdf | 2022-07-07 | English | ||
| 25173714 | News release - English.pdf | 2022-07-07 | English | ||
| 25173730 | News release - English.pdf | 2022-07-07 | English | ||
| 13602011 | Material change report - English.pdf | 2022-07-06 | English | ||
| 13601361 | News release - English.pdf | 2022-07-05 | English | ||
| 13572082 | Material change report - English.pdf | 2022-03-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Afexa Life Sciences Inc.
Researched, developed, and manufactured naturally derived O…
|
FXA | CA | Manufacturing |
|
AFT Pharmaceuticals Limited
Develops, licenses, and distributes pharmaceuticals across …
|
AFT | NZ | Manufacturing |
|
AFT PHARMACEUTICALS LIMITED
Develops and licenses healthcare products for pain manageme…
|
AFP | AU | Manufacturing |
|
AGENUS INC
A clinical-stage biotechnology company specializing in immu…
|
AGEN | US | Manufacturing |
|
AGIOS PHARMACEUTICALS, INC.
Biopharmaceutical company developing therapies for rare and…
|
AGIO | US | Manufacturing |
|
AHN-GOOK PHARMACEUTICAL Co., Ltd.
Develops and markets medicines, focusing on respiratory and…
|
001540 | KR | Manufacturing |
|
AIM Vaccine Co., Ltd.
Develops, manufactures, and commercializes established and …
|
6660 | HK | Manufacturing |
|
AION THERAPEUTIC INC.
Health and wellness company developing AI-driven bio-pharma…
|
AION | CA | Manufacturing |
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
Pure Extracts Technologies Corp. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45792/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45792 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45792 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45792 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45792}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pure Extracts Technologies Corp. (id: 45792)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.